Literature DB >> 6407699

Anticancer chemotherapy.

P Davey, G R Tudhope.   

Abstract

Mesh:

Substances:

Year:  1983        PMID: 6407699      PMCID: PMC1548379          DOI: 10.1136/bmj.287.6385.110

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  7 in total

1.  ICRF 159, (+/-) 1,2-di(3,5-dioxopiperazin-1-yl) propane NSC-129,943; razoxane.

Authors:  M T Bakowski
Journal:  Cancer Treat Rev       Date:  1976-06       Impact factor: 12.111

2.  Biologic-response modifiers and adjuvant chemotherapy: consideration of selected preclinical investigations in relation to clinical potential.

Authors:  A Goldin; M A Chirigos; J S Macdonald; A Fefer; E Mihich
Journal:  Recent Results Cancer Res       Date:  1982

Review 3.  Cancer chemotherapy: new developments and changing concepts.

Authors:  S K Carter
Journal:  Drugs       Date:  1980-11       Impact factor: 9.546

4.  The scientific basis for adjuvant chemotherapy.

Authors:  D S Martin
Journal:  Cancer Treat Rev       Date:  1981-09       Impact factor: 12.111

5.  The acute toxicities of chemotherapy.

Authors:  R J Spiegel
Journal:  Cancer Treat Rev       Date:  1981-09       Impact factor: 12.111

6.  Controlled clinical studies with an antidote against the urotoxicity of oxazaphosphorines: preliminary results.

Authors:  W Scheef; H O Klein; N Brock; H Burkert; U Günther; H Hoefer-Janker; D Mitrenga; J Schnitker; R Voigtmann
Journal:  Cancer Treat Rep       Date:  1979-03

7.  VP-16-213 (etoposide): the mandrake root from Issyk-Kul.

Authors:  N J Vogelzang; D Raghavan; B J Kennedy
Journal:  Am J Med       Date:  1982-01       Impact factor: 4.965

  7 in total
  1 in total

Review 1.  3D tissue-engineered model of Ewing's sarcoma.

Authors:  Salah-Eddine Lamhamedi-Cherradi; Marco Santoro; Vandhana Ramammoorthy; Brian A Menegaz; Geoffrey Bartholomeusz; Lakesla R Iles; Hesham M Amin; J Andrew Livingston; Antonios G Mikos; Joseph A Ludwig
Journal:  Adv Drug Deliv Rev       Date:  2014-08-07       Impact factor: 15.470

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.